Corpus coverage

319,975 slides

319,974 are described (100%), so the treemap can explain the corpus instead of just counting files.

Total slides
319,975
Described
319,974
Pending
1

Slide type composition

dynamicclickable
Slide type

Showing 319,974 described slides — 100.0% of 319,975 rendered pages

Tile area is proportional to slide count. Click a category to open its subtype map.

all document kinds · all orientations

Slide collection

129,901-129,960 of 319,975

filter-aware
66
The slide uses a series of pull-quotes to build a narrative of fraud, specifically highlighting the 'cherry-picking' of patients to skew study results.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller Beat · The Victory1 hit
67
The slide uses testimonials from former executives to build a case of fraud against the company's clinical trial methodology.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller Beat · The Victory1 hit
68
The slide uses yellow highlighting to emphasize key phrases within the quotes, such as 'rigged' and 'manipulated the patients'.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller Beat · The Victory1 hit
69
The slide uses highlighted text to emphasize key accusations of data manipulation and criminal behavior.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller Beat · The Victory1 hit
70
Uses highlighted text to emphasize critical claims from experts.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller Beat · The Victory1 hit
71
Uses highlighted quotes to build a case against the company's core technology claims.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller Beat · The Victory1 hit
72
The slide highlights a specific clinical study (PROCO) to undermine the competitive advantage of the subject company's core technology.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller Beat · The Victory1 hit
73
The slide uses testimonials to undermine the company's core product claim.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller Beat · The Victory1 hit
74
Includes a quote from a 'West coast-based high volume implanter' and a visual annotation of study results.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller Beat · The Victory1 hit
75
The slide uses a quote from a former Medtronic employee to reinforce the argument that the technology is not unique or effective.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller Beat · The Victory1 hit
76
Uses testimonials to undermine the company's core value proposition.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller Beat · The Victory1 hit
77
The slide uses highlighted text to emphasize key pain points regarding battery life and charging frequency.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller Beat · The Victory1 hit
78
Uses direct quotes from company filings and website to frame the 'paresthesia-free' claim as a vulnerability.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller Beat · The Victory1 hit
79
Uses testimonials to contradict the company's marketing claims.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller Beat · The Victory1 hit
80
Uses expert testimony to frame the company's core technology as a liability.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller Beat · The Victory1 hit
81
The slide uses a testimonial to frame the company's core product feature as a business liability.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller Beat · The Victory1 hit
82
The slide uses expert testimony to undermine the company's core value proposition.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller Beat · The Victory1 hit
83
The slide uses testimonials from a former employee to frame management as incompetent and the product as obsolete.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller Beat · The Victory1 hit
84
The slide uses a screenshot of a Nevro investor presentation to expose a contradiction in their reported explant rates.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller Beat · The Victory1 hit
85
The slide uses a screenshot of a medical journal article to highlight author conflicts of interest and a table of explant data to challenge the company's claims.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller Beat · The Victory1 hit
86
The slide uses a red circle to highlight a specific table from a medical paper, emphasizing the discrepancy between real-world outcomes and company claims.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller Beat · The Victory1 hit
87
The slide uses a series of quotes from KOLs (Key Opinion Leaders) to build a narrative of systemic failure and industry skepticism.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller Beat · The Victory1 hit
88
The slide uses direct quotes from a KOL to frame the company's behavior as unethical and retaliatory.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller Beat · The Victory1 hit
89
Uses testimonial-style quotes to build a narrative of corporate deception regarding product failure rates.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller Beat · The Victory1 hit
90
The slide uses testimonials to build a narrative of industry-wide dissatisfaction and lack of transparency regarding explant data.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller Beat · The Victory1 hit
91
The slide uses highlighted quotes to emphasize the severity of the alleged device failures and the high volume of Nevro patients requiring salvage therapy.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller Beat · The Victory1 hit
92
Uses highlighted quotes to emphasize negative feedback from medical professionals.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller Beat · The Victory1 hit
93
Uses expert testimony to challenge official company data.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller Beat · The Victory1 hit
94
Uses testimonial-style quotes from competitor employees to undermine company disclosures.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller Beat · The Victory1 hit
95
The slide uses a 'case study' format to provide qualitative evidence of product failure.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller Beat · The Victory1 hit
96
The slide uses highlighted text to emphasize key negative performance metrics and qualitative feedback.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller Beat · The Victory1 hit
97
Case study #3 of 5.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller Beat · The Victory1 hit
98
The slide uses highlighted text to emphasize critical data points regarding patient satisfaction and explant rates.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller Beat · The Victory1 hit
99
The slide uses highlighted text to emphasize key allegations of fraud and data manipulation.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller Beat · The Victory1 hit
100
The slide uses a 'case study' format to expose product failure and corporate ethics issues.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller Beat · The Victory1 hit
101
The slide uses highlighted text to emphasize critical claims about medical device safety and physiological impact.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller Beat · The Victory1 hit
102
The slide uses a pull-quote to highlight negative sentiment from a key opinion leader.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller Beat · The Victory1 hit
103
The slide uses highlighted text to emphasize key negative sentiment regarding Nevro's product reliability and transparency.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller Beat · The Victory1 hit
104
The slide uses highlighted text to emphasize critical quotes from a medical professional.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller Beat · The Victory1 hit
105
The slide presents a qualitative case study (KOL #5) to support the thesis of widespread device failure.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller Beat · The Victory1 hit
106
The slide uses direct quotes from two KOLs to highlight perceived contradictions between their public statements and the reality of device performance.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller Beat · The Victory1 hit
107
The slide uses heavy yellow highlighting to emphasize damning statements from anonymous industry experts.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller Beat · The Victory1 hit
108
The slide uses direct quotes from former consultants to substantiate claims of corporate misconduct.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller Beat · The Victory1 hit
109
The slide uses direct quotes from KOLs to frame the company's management as deceptive and manipulative.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller Beat · The Victory1 hit
110
The slide uses a direct quote to frame the company's behavior as deceptive.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller Beat · The Victory1 hit
111
The slide uses direct quotes from KOLs to frame the company as unethical and manipulative.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller Beat · The Victory1 hit
112
The slide uses highlighted text to emphasize key claims about doctor behavior and financial incentives.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller Beat · The Victory1 hit
113
The slide uses aggressive, accusatory language and highlights specific quotes from KOLs to frame Nevro's business practices as unethical and similar to the Insys scandal.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller Beat · The Victory1 hit
114
Uses a 'gotcha' interview format to frame the company's business model as deceptive.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller Beat · The Victory1 hit
115
Uses testimonial evidence from KOLs to support the claim of corporate deception.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller Beat · The Victory1 hit
116
The slide uses a direct quote from a KOL to frame the company's sales tactics as unethical and deceptive.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller Beat · The Victory1 hit
117
Uses testimonial-style quotes from KOLs to build a case of corporate misconduct.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller Beat · The Victory1 hit
118
The slide uses direct quotes from consultants to substantiate claims of corporate misconduct.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller Beat · The Victory1 hit
119
The slide uses direct quotes from a KOL to support the claim of unethical sales practices and patient manipulation.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller Beat · The Victory1 hit
120
Uses testimonials to frame the company as a 'one-tick pony' with a shrinking user base.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller Beat · The Victory1 hit
121
Uses direct quotes to frame Nevro as a 'one-trick pony' lacking sophistication compared to competitors.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller Beat · The Victory1 hit
122
Uses direct quotes to undermine the company's value proposition.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller Beat · The Victory1 hit
123
The slide uses expert testimony to frame Nevro's business model as unsustainable once 'low-hanging fruit' markets are exhausted.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller Beat · The Victory1 hit
124
The slide uses highlighted text to emphasize key claims about market share loss and device failure.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller Beat · The Victory1 hit
125
The slide uses expert testimony to undermine the company's market position and stock performance.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller Beat · The Victory1 hit